The following members have been nominated for positions on the AIMOS Board for terms commencing in 2026. They are listed in alphabetical order, by family name.

Xanthi Coskinas

I am deeply motivated by improving the trustworthiness and transparency of scientific research. With more than two decades of experience managing national and international clinical trials, I have seen first-hand how unplanned methodological changes—often well-intentioned—can affect credibility and reproducibility. This experience inspired my PhD and the development of the TRACE-RCT framework, which examines when and how such changes occur and how they can be transparently documented. As a biostatistics program manager and researcher at the University of Sydney’s NHMRC Clinical Trials Centre, I focus on trial transparency, supervise emerging researchers, and collaborates across epidemiology, biostatistics, evidence synthesis, ethics, and implementation science to embed openness in everyday research practice.

I want to serve on the AIMOS Board to help foster a research culture where transparency and reproducibility are not just ideals but norms. My commitment is both scholarly and practical—reflected in my ongoing TRACE-RCT work, an accepted Lightning Talk at the 2025 AIMOS Conference (led by my student under co-supervision), and my upcoming presentation at the International Research Integrity Conference. I believe AIMOS provides a vital bridge between rigorous meta-research and real-world change and would bring extensive experience in clinical trials, stakeholder engagement, and research transparency and reform to help sustain and scale its impact. I aim to contribute to AIMOS’ strategic growth by strengthening institutional partnerships and increasing the visibility of open science practices in research settings.

Soumyadeep Bhaumik

I am a medical doctor and public health methodologist by training with a strong interest in meta-research mostly focussed on research priority setting, guideline development, ethics, and equitable knowledge systems. I currently head the global Meta-research and Evidence Synthesis Unit at the George Institute for Global Health and Conjoint Senior Lecturer at UNSW. My work spans to evidence synthesis, interpretive health policy analysis, and the ethical governance of AI in health research. I bring experience in interdisciplinary collaboration, global health, and pro-justice research practice. I seek to contribute to AIMOS’s mission and help strengthen its reach across disciplines and geographies. I am well-positioned to do so having previously worked across multiple continents including as Co-Convenor of Cochrane Priority Setting Methods Group and several committees nationally,sub-nationally and in multi-national forums.

Gina Grimshaw

Aidan Tan

Gina Grimshaw is a Professor of Psychology at te Herenga Waka - Victoria University of Wellington, and a Principal Investigator in Te Pūnaha Matatini, the New Zealand Centre of Research Excellence in Complex Systems. I am a strong advocate for open science practices and has incorporated them into my teaching in research methods and statistics. I also have an academic interest in ways to stimulate, support, and evaluate interdisciplinary research. I will be co-hosting AIMOS 2026 in Wellington, New Zealand.

I’ve had the privilege of serving on the AIMOS Board since 2023 and as Treasurer during a time of growth and deep reflection for our community. I care about AIMOS because I believe in its purpose: to strengthen the integrity and impact of science. My work as a clinician, researcher, and policy advisor has shown me how much depends on the reliability of evidence. When research falls short of being reproducible or rigorous, it undermines trust and harms the people we intend to serve.

Through AIMOS, I’ve seen how collaboration across disciplines can repair that gap. I’ve contributed to financial stewardship, strategic planning, and conference programming, but what I value most is the shared culture of openness and respect that defines AIMOS.

I hope to continue bringing a systems-level perspective to the Board, linking governance with research practice and keeping equity, transparency, and accountability at the heart of what we do. The work of AIMOS matters far beyond academia. It speaks to how society values truth, evidence, and integrity. I’d be honoured to continue helping AIMOS grow as a strong, inclusive community that leads by example in improving the quality of science.